Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Salim

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Pharmacogenetics and Genomics|December 27, 2017
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated lociLara E Sucheston-Campbell, Alyssa I Clay-Gilmour, William E Barlow, et al.
The Lancet Regional Health. Southeast Asia|October 10, 2025
Seroprevalence of IgG antibodies against hepatitis-A infection among individuals aged 6-30 years in India, 2021: a nationwide population-based cross-sectional studyMuthusamy Santhosh Kumar, Chethrapilly Purushothaman Girish Kumar, Velusamy Saravanakumar, et al.
Plos Medicine|December 10, 2021
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional studyManoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Cancer|September 23, 2025
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFTKarin Ribi, Bernard F Cole, Gini F Fleming, et al.
JAMA Network Open|November 3, 2025
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer IndexRuth M O'Regan, Yue Ren, Yi Zhang, et al.
BMJ Open|September 24, 2021
Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020S Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
Frontiers in Public Health|October 24, 2022
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, IndiaKouser Sideeq Lone, S Muhammad Salim Khan, Mariya Amin Qurieshi, et al.
The Indian Journal of Medical Research|February 12, 2024
Correlation of severity & clinical outcomes of COVID-19 with virus variants: A prospective, multicentre hospital network studyKomal Wadhwa, Shilpa Malik, Srinigila Balaji, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Indian Journal of Medical Research|September 21, 2020
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Pharmacogenetics and Genomics|December 27, 2017
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated lociLara E Sucheston-Campbell, Alyssa I Clay-Gilmour, William E Barlow, et al.
The Lancet Regional Health. Southeast Asia|October 10, 2025
Seroprevalence of IgG antibodies against hepatitis-A infection among individuals aged 6-30 years in India, 2021: a nationwide population-based cross-sectional studyMuthusamy Santhosh Kumar, Chethrapilly Purushothaman Girish Kumar, Velusamy Saravanakumar, et al.
Plos Medicine|December 10, 2021
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional studyManoj V Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
Cancer|September 23, 2025
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFTKarin Ribi, Bernard F Cole, Gini F Fleming, et al.
JAMA Network Open|November 3, 2025
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer IndexRuth M O'Regan, Yue Ren, Yi Zhang, et al.
BMJ Open|September 24, 2021
Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020S Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
Frontiers in Public Health|October 24, 2022
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, IndiaKouser Sideeq Lone, S Muhammad Salim Khan, Mariya Amin Qurieshi, et al.
The Indian Journal of Medical Research|February 12, 2024
Correlation of severity & clinical outcomes of COVID-19 with virus variants: A prospective, multicentre hospital network studyKomal Wadhwa, Shilpa Malik, Srinigila Balaji, et al.
The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Indian Journal of Medical Research|September 21, 2020
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020Manoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
Pageof 13